Wright Medical launches new Australian subsidiary

Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical device company, today announced that it has launched a new subsidiary, Wright Medical Australia Pty, LTD. The new entity will directly manage all of the Company’s extremity and biologics distribution for customers in Australia and New Zealand.

The creation of Wright Medical Australia is a pivotal move that will facilitate the Company’s long-term objective of launching a more comprehensive portfolio of products to address the needs of specific customer segments in that region. The development also aligns with Wright’s larger strategic vision of achieving focused selling through specialized distribution channels.

“Wright is extremely pleased to add the Wright Medical Australia entity to our global family of subsidiaries,” commented Karen L. Harris, Wright’s Sr. Vice President of International. “The new subsidiary will provide Wright with enhanced control over distribution activities, as well as the invaluable leadership of a highly experienced and focused team of professionals with specialized knowledge in the extremity field and successful histories in the Australian market.”

As a complement to its new direct extremity and biologics subsidiary, Wright has also enhanced its reconstructive joint sales capabilities in Australia through an agreement with distributor LSS Pty, Ltd. Wright’s reconstructive joint product distribution through this highly energized and dynamic organization will begin in Australia and New Zealand during the fourth quarter of 2009.

Wright Medical Group, Inc. is a global orthopaedic medical device company specializing in the design, manufacture and marketing of reconstructive joint devices and biologics. The Company has been in business for more than 50 years and markets its products in over 60 countries worldwide. For more information about Wright Medical, visit the company’s website at www.wmt.com.

http://www.wmt.com/